Research work · 2011

PAX5–PML acts as a dual dominant-negative form of both PAX5 and PML

Shingo Kurahashi, Fumihiko Hayakawa, Yasuyoshi Miyata, Takahiko Yasuda, Y Minami, Shinobu Tsuzuki, A Abe, Takashi Naoe

Oncogene

DOI: 10.1038/onc.2010.554